Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-022014
Filing Date
2020-05-06
Accepted
2020-05-06 16:47:07
Documents
67
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q myok-10q_20200331.htm   iXBRL 10-Q 1942083
2 EX-10.2 myok-ex102_46.htm EX-10.2 55921
3 EX-10.3 myok-ex103_45.htm EX-10.3 17635
4 EX-31.1 myok-ex311_8.htm EX-31.1 15754
5 EX-31.2 myok-ex312_9.htm EX-31.2 15838
6 EX-32.1 myok-ex321_10.htm EX-32.1 8704
  Complete submission text file 0001564590-20-022014.txt   6611481

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA myok-20200331.xsd EX-101.SCH 42354
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE myok-20200331_cal.xml EX-101.CAL 47814
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE myok-20200331_def.xml EX-101.DEF 101593
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE myok-20200331_lab.xml EX-101.LAB 320938
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE myok-20200331_pre.xml EX-101.PRE 237419
32 EXTRACTED XBRL INSTANCE DOCUMENT myok-10q_20200331_htm.xml XML 1243456
Mailing Address 1000 SIERRA POINT PARKWAY BRISBANE CA 94005
Business Address 1000 SIERRA POINT PARKWAY BRISBANE CA 94005 650-741-0900
MyoKardia, Inc. (Filer) CIK: 0001552451 (see all company filings)

EIN.: 455500552 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37609 | Film No.: 20853283
SIC: 2834 Pharmaceutical Preparations